HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravitreal bevacizumab for perifoveal telangiectasia.

AuthorsJost B Jonas, Teodosio Libondi, Stefan von Baltz, Sven Beutelspacher
JournalActa ophthalmologica (Acta Ophthalmol) Vol. 89 Issue 7 Pg. e607-8 (Nov 2011) ISSN: 1755-3768 [Electronic] England
PMID20946328 (Publication Type: Letter)
Chemical References
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
Topics
  • Angiogenesis Inhibitors (administration & dosage)
  • Antibodies, Monoclonal, Humanized (administration & dosage)
  • Bevacizumab
  • Female
  • Fluorescein Angiography
  • Humans
  • Intravitreal Injections
  • Male
  • Retinal Telangiectasis (classification, diagnosis, drug therapy)
  • Retreatment
  • Retrospective Studies
  • Tomography, Optical Coherence
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors)
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: